-
NUMBER OF INSIDER BUYING
(Last 12 Months)
2 -
NUMBER OF INSIDER SELLING
(Last 12 Months)
6 -
AMOUNT OF INSIDERS BUYING
(Last 12 Months)
$219,391 -
AMOUNT OF INSIDERS SELLING
(Last 12 Months)
$495,115
Zentalis Pharmaceuticals, Inc. Insider Transactions
Zentalis Pharmaceuticals, Inc. Insider Trades History
| Insider Name | Buy/Sell | Shares Bought/Sold @ Price |
Total Transaction | Shares Held After Transaction |
Transaction Date | Filing Date | Details |
|---|---|---|---|---|---|---|---|
|
Vultaggio Vincent
Principal Accounting Officer |
Sell | 1,603 @ $3.18 | $5,098 | 33,855 | 10/04/2024 | 10/04/2024 | |
|
Gallagher Cam
Director, President, Interim CFO |
Sell | 9,597 @ $11.98 | $114,972 | 633,680 | 05/31/2024 | 05/31/2024 | |
|
HAUSMAN DIANA
Chief Medical Officer |
Sell | 3,356 @ $12.62 | $42,353 | 373,876 | 05/09/2024 | 05/09/2024 | |
| Sell | 2,573 @ $11.44 | $29,435 | 451,449 | 02/12/2024 | 02/12/2024 | ||
|
Gallagher Cam
Director, President |
Sell | 1,173 @ $11.44 | $13,419 | 643,277 | 02/12/2024 | 02/12/2024 | |
|
Lackner Mark
Chief Scientific Officer |
Sell | 1,585 @ $11.54 | $18,291 | 195,728 | 02/02/2024 | 02/05/2024 | |
|
Paul Andrea
Chief Legal Officer |
Sell | 3,310 @ $11.54 | $38,197 | 149,973 | 02/02/2024 | 02/05/2024 | |
|
Gallagher Cam
Director, President |
Sell | 11,552 @ $11.54 | $133,310 | 644,450 | 02/02/2024 | 02/05/2024 | |
| Sell | 8,669 @ $11.54 | $100,040 | 454,022 | 02/02/2024 | 02/05/2024 | ||
| Buy | 5,000 @ $10.29 | $51,448 | 254,800 | 11/13/2023 | 11/13/2023 | ||
|
Johnson David Michael
Director |
Buy | 17,000 @ $9.88 | $167,943 | 144,389 | 11/10/2023 | 11/13/2023 | |
|
Brownstein Carrie
Chief Medical Officer |
Sell | 8,906 @ $19.43 | $173,012 | 107,407 | 10/04/2023 | 10/06/2023 | |
|
Brownstein Carrie
Chief Medical Officer |
Sell | 1,722 @ $19.91 | $34,285 | 105,685 | 10/04/2023 | 10/06/2023 | |
|
Bunker Kevin D.
Chief Scientific Officer |
Sell | 5,085 @ $19.43 | $98,784 | 860,072 | 10/04/2023 | 10/06/2023 | |
|
Bunker Kevin D.
Chief Scientific Officer |
Sell | 983 @ $19.91 | $19,572 | 859,089 | 10/04/2023 | 10/06/2023 | |
| Sell | 4,594 @ $19.43 | $89,245 | 388,579 | 10/04/2023 | 10/06/2023 | ||
| Sell | 888 @ $19.91 | $17,680 | 387,691 | 10/04/2023 | 10/06/2023 | ||
|
Skvarka Jan
Director |
Sell | 5,000 @ $25.05 | $125,238 | 47,970 | 09/11/2023 | 09/13/2023 | |
|
Matrix Capital Management Company, LP
10 percent owner |
Buy | 4,760,000 @ $22.66 | $107.86 M | 13,959,973 | 06/20/2023 | 06/20/2023 | |
|
Gallagher Cam
Director, President |
Sell | 9,242 @ $26.40 | $243,979 | 482,028 | 05/31/2023 | 05/31/2023 |
Zentalis Pharmaceuticals, Inc. Frequently Asked Questions
-
Who is on Zentalis Pharmaceuticals, Inc.'s Insider Roster?
The list of insiders at Zentalis Pharmaceuticals, Inc. includes Johnson David Michael, Blackwell Kimberly, Epperly Melissa B,, Gallagher Cam, Paul Andrea, Lackner Mark, HAUSMAN DIANA, Vultaggio Vincent.
-
How much insider selling is happening at Zentalis Pharmaceuticals, Inc.?
Insiders have sold a total of 43,418 Zentalis Pharmaceuticals, Inc. shares in the last 12 months for a total of 495,115 sold.
-
Which Zentalis Pharmaceuticals, Inc. insiders have been selling company stock?
The following insiders have sold Zentalis Pharmaceuticals, Inc. shares in the last 12 months: Epperly Melissa B, ($129,475), Gallagher Cam ($261,701), Paul Andrea ($38,197), Lackner Mark ($18,291), HAUSMAN DIANA ($42,353), Vultaggio Vincent ($5,098),
-
How much insider buying is happening at Zentalis Pharmaceuticals, Inc.?
Insiders have purchased a total of 22,000 Zentalis Pharmaceuticals, Inc. shares in the last 12 months for a total of 219,391 sold.
-
Which Zentalis Pharmaceuticals, Inc. insiders have been buying company stock?
The following insiders have purchased Zentalis Pharmaceuticals, Inc. shares in the last 12 months: Johnson David Michael ($167,943), Blackwell Kimberly ($51,448),